Biomea Fusion BMEA
NASDAQ BMEA
$0.69 -0.05 (-6.19%)
At close: Oct 21, 2026 · 4:00 PM EDT

Biomea Fusion (BMEA) Return on Capital Employed [ROCE] (2021 - 2026)

Updated

Biomea Fusion's Return on Capital Employed [ROCE] was -186.43% in Q2 2026, up 60.89 percentage points from -247.31% a year earlier but down 32.26 percentage points from the prior quarter.

Analysis

Biomea Fusion (BMEA) Return on Capital Employed [ROCE] (2021 - 2026) Analysis & Trends

For FY2025, Return on Capital Employed [ROCE] at Biomea Fusion came in at -143.60%, down 21.78 percentage points from FY2024.

  • Return on Capital Employed [ROCE] has now declined for four consecutive years, with a four-year change of -108.73 percentage points (FY2021 to FY2025).
  • In earlier years, Return on Capital Employed [ROCE] was -121.83% in FY2024 (-32.85 pp), -88.98% in FY2023 (-28.55 pp), -60.43% in FY2022 (-25.55 pp) and -34.87% in FY2021.
  • Quarterly Return on Capital Employed [ROCE] has moved between -278.36% (Q1 2025) and -15.30% (Q3 2021) over five years.
  • Compared with a year earlier, Return on Capital Employed [ROCE] has increased for three straight quarters, with an average year-over-year change of -51.37 percentage points over the last eight quarters.
  • The best year-over-year quarter for Return on Capital Employed [ROCE] over five years was Q1 2026 (a gain of 124.20 percentage points); the worst was Q1 2025 (a drop of 192.08 percentage points).
  • Per Business Quant data, BMEA's Return on Capital Employed [ROCE] in the three quarters before Q2 2026 was -154.16% (Q1 2026), -182.43% (Q4 2025) and -209.56% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROCE (Qtr)
1 Eli Lilly 1,136.97 Bn 1,105.55 Bn 19.71 Bn 46.74%
2 Johnson & Johnson 619.72 Bn 538.25 Bn 17.26 Bn 17.83%
3 AbbVie 503.40 Bn 476.52 Bn 12.70 Bn 17.92%
4 Merck 370.15 Bn 324.53 Bn 12.21 Bn 6.28%
5 Novartis Ag 298.64 Bn 262.63 Bn 11.24 Bn 19.32%
6 Astrazeneca 261.07 Bn 234.76 Bn 12.86 Bn 16.76%
7 Amgen 237.00 Bn 192.40 Bn 7.24 Bn 16.66%
8 Gilead Sciences 191.24 Bn 165.43 Bn 6.22 Bn -5.97%
9 Pfizer 170.31 Bn 116.96 Bn 10.94 Bn 11.86%
10 Biomea Fusion 50.53 Mn -131.81 Mn - -186.43%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -186.43%
Mar 31, 2026 -154.16%
Dec 31, 2025 -182.43%
Sep 30, 2025 -209.56%
Jun 30, 2025 -247.31%
Mar 31, 2025 -278.36%
Dec 31, 2024 -196.00%
Sep 30, 2024 -158.09%
Jun 30, 2024 -116.70%
Mar 31, 2024 -86.29%
Dec 31, 2023 -66.51%
Sep 30, 2023 -52.15%
Jun 30, 2023 -64.61%
Mar 31, 2023 -95.17%
Dec 31, 2022 -70.83%
Sep 30, 2022 -51.20%
Jun 30, 2022 -38.54%
Mar 31, 2022 -30.30%
Dec 31, 2021 -22.17%
Sep 30, 2021 -15.30%
API Access

Biomea Fusion Return on Capital Employed [ROCE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-capital-employed-%5Broce%5D&ticker=BMEA&period=max&api_key=YOUR_API_KEY